April prone to weakness after tax deadline.
How the healthcare overhaul initially reflects in pricing of medical devices and affect drugs as Amgen and Stryker both report. Is the market preparing for the old time traditional "sell in May," and the market flattens for several months. Everything in the recent past has been different.
The market is simple to respond to. Earnings are good, euphoria is up, and no one really gives a s__t that Goldman Sachs (and all the banks robbed us for years). Watch for new market toppings near 10,267 or drops on any bad earnings.
The call was available for $1.00 profits by 2.00 p.m. We will watch on any more upside for a new entry to the put as a hedge in this volatile market.
No comments:
Post a Comment